L Arivazhagan, CJ Popp, HH Ruiz… - Cardiovascular …, 2023 - academic.oup.com
Overweight and obesity are leading causes of cardiometabolic dysfunction. Despite extensive investigation, the mechanisms mediating the increase in these conditions are yet …
BACKGROUND Advanced glycation end products (AGEs) and their receptors are regarded as central to the development of diabetic complications, but associations with diabetes and …
Cardiometabolic disorders are characterised by a cluster of interactive risk determinants such as increases in blood glucose, lipids and body weight, as well as elevated …
S Reichert, U Triebert, AN Santos, B Hofmann… - Atherosclerosis, 2017 - Elsevier
Background and aims Soluble RAGE (sRAGE) serum level could be a biomarker for atherosclerosis and subsequent diseases such as cardiovascular disease (CVD). Therefore …
ER Miranda, VS Somal, JT Mey… - American Journal …, 2017 - journals.physiology.org
The soluble receptor for advanced glycation end products (sRAGE) may be protective against inflammation associated with obesity and type 2 diabetes (T2DM). The aim of this …
Background and aims The receptor for advanced glycation end products (RAGE) is implicated in obesogenesis. Conversely, soluble RAGE (sRAGE) competitively inhibits …
Obesity, a chronic multifaceted disease, predisposes its patients to increased risk of metabolic disorders such as: diabetes mellitus, cardiovascular diseases, dyslipidemia, etc …
Several epidemiologic studies have evaluated the relation between serum/plasma brain- derived neurotrophic factor (BDNF) levels and glycemic parameters, but the findings were …
BJ Wang, MM Hao, QL Yang, J Li, YH Guo - Journal of assisted …, 2016 - Springer
Purpose To explore the relationships between the soluble receptor for advanced glycation endproducts (sRAGE) and the outcome parameters following in vitro fertilization-embryo …